The capsule endoscopy market is projected to grow from $0.69 billion in 2024 to $1.15 billion by 2029, driven by the increasing prevalence of gastrointestinal disorders, demand for non-invasive diagnostics, and advancements in AI-powered and magnetically controlled capsule technology. Key players include Medtronic, Fujifilm, Boston Scientific, and Olympus, with North America leading the market. Emerging trends such as biodegradable capsules and telemedicine integration are expected to further expand market adoption.
Keep Reading
Add A Comment